Navigation Links
SpongeTech Delivery Systems, Inc. to Donate to The Darryl Strawberry Foundation!!
Date:4/1/2008

ecially formulated soaps and wax that are released when the sponge is applied to a surface with minimal pressure. The Company's products are currently designed specifically for vehicular cleaning use. However, the Company is exploring the possibility of using its patented technology for the development of sponges for other uses, including for use with anti-bacterial, bath and kitchen soaps for household uses, as well as for use as a children's bath foam sponge.

"Safe Harbor Statement" Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The results anticipated by any or all of these forward-looking statements may not occur. Additional risks and uncertainties are set forth in the Company's Annual Report on Form 10-KSB for the year ended December 31, 2005, the Company's Quarterly Report on Form 10-QSB for the first quarter ended March 31, 2006. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.

Contact:

SpongeTech(R) Delivery Systems, Inc.

Investor Relations: 1-877-776-6438

info@spongetech.com


'/>"/>
SOURCE SpongeTech Delivery Systems Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Scientific Publications Strategy & Delivery Shifts from Marketing to Medical
2. Serta Brings Sweet Dreams and a Special Delivery to Deserving Women
3. Dr. Louis Sullivans Symphony of Health Care Delivery Stresses Importance of Communication, Quality Research in Health Care
4. Nastech Pharmaceutical Company Announces Promotion of Rick Costantino, Ph.D., to Chief Scientific Officer of Delivery
5. Nastech Pharmaceutical Company Announces the Jeffrey Wenig Memorial Award for Outstanding Achievement in Drug Delivery
6. Developing a modular, nanoparticle drug delivery system
7. QLT acquires leading edge ocular drug delivery system from ForSight Labs
8. Varian Medical Systems to Unveil RapidArc(TM) Volumetric Arc Therapy and Other Products Designed to Speed Delivery of Precision Radiotherapy and Brachytherapy
9. HHS Secretary Leavitt Signs Agreement With Canada to Improve Indigenous Health Care Delivery and Access
10. LeMaitre Vascular Launches Next-Generation Stent Graft Delivery System
11. it Girl Public Relations Adds O.N.I. New Organic Food Delivery Service to Its Lifestyle Division
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...r an Injunction in Federal Court to Reclaim Overti...swire-USNewswire/ -- Registered nurses for Riversi... Medical Center, filed a Fair Labor Standards Act ...y to stop the county from violating federal law go... are seeking to represent all 867 registered nurse...
(Date:12/2/2008)...ire-USNewswire/ -- Are you unhappy with your smile... are available? , , The Pennsylvania Dental...metic options exist to improve your smile. Your de...tory to determine a suitable option to help restor...tic dental options. , , , , To...
(Date:12/2/2008)...edical Center ranks No. 1 nationwide for the speed...g balloon angioplasty, according to the National C... (Vocus) December 2, 2008 -- UCSF Medi...th which heart attack patients are treated using b...iovascular Data Registry (NCDR). Cardiac balloon ...
(Date:12/2/2008)...Breast-Specific Gamma Imaging (BSGI) has,been pro... the diagnosis of,invasive lobular carcinoma (ILC... a molecular breast imaging technique that can see...er very early stage cancers. When compared to,mam...g (MRI), BSGI has the,greatest sensitivity for de...
Breaking Medicine News(10 mins):Health News:Riverside County Registered Nurses File a Lawsuit to Stop County's Violation of Federal Law 2Health News:Cosmetic Dentistry: A Beautiful Smile Is Not Far Away 2Health News:UCSF Medical Center Leads Nation in ER Heart Attack Care 2Health News:UCSF Medical Center Leads Nation in ER Heart Attack Care 3Health News:Molecular Breast Imaging Has Greater Sensitivity Over Mammography, Ultrasound and MRI for Invasive Lobular Carcinoma 2
...can make a difference. //Three-quarters of physici...a new study says they could be wrong. The new rese...ve at relieving back pain. Physicians often get f...pe of bed is best for their lower back pain. Few s...
...he Commonwealth's restaurants, taverns, and nightc...liquor-store sales as the House and Senate conclud.../ Working until nearly midnight, lawmakers also ap...to spur shoppers to spend more, thereby pumping up...
...t on a bill that would a prescription drug benefit...the politically popular entitlement program in its...lined up in our favor," House Speaker Dennis Haste...erence in the Capitol. "The time is upon us. It's ...
...arin in reducing stroke among people with an irreg...rug ximelagatran appears to be as effective as war...ople at high risk of stroke because of its blood t...he drawbacks of warfarin include an increased risk...
Other Medicine News:Health News:Senate assures ban on smoking 2Health News:Senate assures ban on smoking 3Health News:Senate assures ban on smoking 4Health News:House heads for Medicare drug vote, 2Health News:House heads for Medicare drug vote, 3
(Date:12/1/2008)...te Ltd today announced the initiation of a Phase 1...ctive JAK2 inhibitor, in leading medical centers i...yelofibrosis (CIMF). , , The trial is desi...1518 in patients with CIMF and is expected to enro...y will assess the safety profile and evaluate the ...
(Date:12/1/2008)...ith ENB-0040 at Children,s Hospital, Health Scienc... Enobia Pharma, an emerging Canadia...apeutics for serious bone disorders, today announc...rogram for hypophosphatasia was dosed. Enobia is i... ENB-0040 for the treatment of this rare and often...
(Date:12/1/2008)... , , ROCHESTER, Minn., Dec. 1 /PRNewswire-...the use of the drug therapy etanercept ineffective...ation of the liver caused by excessive consumption...d in the December issue of Gastroenterology ( ht...LERT: Additional audio and video resources, includ...
(Date:12/1/2008)...swire-FirstCall/ -- Following a,Request for Propo...VA-based,third generation smallpox vaccine, Publ...f of the Canadian Department of National Defence, ... delivery of IMVAMUNE(R). , The Canadian au...,country,s bio-preparedness programme. , T...
Breaking Medicine Technology:S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3The impact of physical activity on weight bearing knee joint 2297 1The impact of physical activity on weight bearing knee joint 2297 2The impact of physical activity on weight bearing knee joint 2297 3Babies raised in bilingual homes learn new words differently than infants learning one language 2295 1Babies raised in bilingual homes learn new words differently than infants learning one language 2295 2Babies raised in bilingual homes learn new words differently than infants learning one language 2295 3Painful condition affecting kidney failure patients increases risk of death 2293 1Painful condition affecting kidney failure patients increases risk of death 2293 2Painful condition affecting kidney failure patients increases risk of death 2293 3APHA Urges President Bush Not To Veto CHIP 3B Were Only One Signature Away from Protecting the Health of Our Children 2291 1APHA Urges President Bush Not To Veto CHIP 3B Were Only One Signature Away from Protecting the Health of Our Children 2291 2
... WIRE)--Mar 26, 2007 - Inovio Biomedical Corp.,(AM...A vaccines and,a novel solid tumor ablation therap...s published a scientific paper prepared by,Inovio,...om a,non-human primate study of an investigational...omedical,s electroporation technology.,The paper, ...
...Outpatient Infusion Study in Patients with,Chronic...ican,College of Cardiology 56th Annual Scientific ... March 25, 2007,/PRNewswire/ -- Scios Inc. announc... study of nesiritide (NATRECOR(R)) showed a,neutra...eath and,cardiorenal hospitalization at 12 weeks, ...
Other Medicine Technology:Inovio Biomedical's DNA Delivery Technology Significantly Enhances,Potency of HIV DNA Vaccine 2Inovio Biomedical's DNA Delivery Technology Significantly Enhances,Potency of HIV DNA Vaccine 3Inovio Biomedical's DNA Delivery Technology Significantly Enhances,Potency of HIV DNA Vaccine 4Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 2Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 3Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 4Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 5Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 6Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 7
...fely, the Hoefer GD 2000 uses a dry-heat vacuum me...through a heavy aluminum platen. , Dries acrylami...as thirty minutes., The heavy aluminum platen prov...bution under the gel., A clear silicone cover shee...
...ilizes a hot air drying device for polyacrylamide ...g frames at once. Gels are dried on a clear cellop...is recessed to provide a smooth, flat assembly sur...m includes a gel drying oven, 2 drying frames, 16 ...
The PRO6000 power supply is the latest edition to Thermo's power supply product offering. It sets new standards in proteomic and genomic electrophoresis. This product has unique features dedicated to
Capable of producing up to 500 volts and 500 milliamps, this power supply is ideal for PAGE, SDS-PAGE, DNA or RNA submarine gels as well as all types of small format transfer apparatus.
Medicine Products: